Depreciation of Enlivex Therapeutics Ltd. from 31 Dec 2012 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Enlivex Therapeutics Ltd. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2012 to 30 Jun 2025.
  • Enlivex Therapeutics Ltd. Depreciation for the quarter ending 30 Jun 2025 was $85,000, a 47% decline year-over-year.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2024 was $545,000, a 35% decline from 2023.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2023 was $835,000, a 7.5% increase from 2022.
  • Enlivex Therapeutics Ltd. annual Depreciation for 2022 was $777,000, a 42% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Enlivex Therapeutics Ltd. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $85,000 -$75,000 -47% 01 Apr 2025 30 Jun 2025 6-K 29 Aug 2025 2025 Q2
Q2 2024 $160,000 01 Apr 2024 30 Jun 2024 6-K 29 Aug 2025 2025 Q2
Q2 2022 $176,000 +$54,000 +44% 01 Apr 2022 30 Jun 2022 6-K 22 Aug 2022 2022 Q2
Q2 2021 $122,000 +$62,000 +103% 01 Apr 2021 30 Jun 2021 6-K 22 Aug 2022 2022 Q2
Q2 2020 $60,000 -$32,000 -35% 01 Apr 2020 30 Jun 2020 6-K/A 13 Oct 2020 2020 Q2
Q2 2019 $92,000 01 Apr 2019 30 Jun 2019 6-K/A 13 Oct 2020 2020 Q2

Enlivex Therapeutics Ltd. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $545,000 -$290,000 -35% 01 Jan 2024 31 Dec 2024 20-F 30 Apr 2025 2024 FY
2023 $835,000 +$58,000 +7.5% 01 Jan 2023 31 Dec 2023 20-F 30 Apr 2025 2024 FY
2022 $777,000 +$231,000 +42% 01 Jan 2022 31 Dec 2022 20-F 30 Apr 2025 2024 FY
2021 $546,000 +$260,000 +91% 01 Jan 2021 31 Dec 2021 20-F 30 Apr 2024 2023 FY
2020 $286,000 +$80,000 +39% 01 Jan 2020 31 Dec 2020 20-F 10 Apr 2023 2022 FY
2019 $206,000 +$85,000 +70% 01 Jan 2019 31 Dec 2019 20-F 29 Apr 2022 2021 FY
2018 $121,000 +$38,000 +46% 01 Jan 2018 31 Dec 2018 20-F 30 Apr 2021 2020 FY
2017 $83,000 +$45,000 +118% 01 Jan 2017 31 Dec 2017 20-F 30 Apr 2020 2019 FY
2016 $38,000 +$21,000 +124% 01 Jan 2016 31 Dec 2016 20-F/A 23 Jan 2020 2018 FY
2015 $17,000 +$12,000 +240% 01 Jan 2015 31 Dec 2015 20-F 23 Apr 2018 2017 FY
2014 $5,000 +$5,000 01 Jan 2014 31 Dec 2014 20-F 24 Feb 2017 2016 FY
2013 $0 $0 01 Jan 2013 31 Dec 2013 20-F 29 Mar 2016 2015 FY
2012 $0 01 Jan 2012 31 Dec 2012 20-F 31 Mar 2015 2014 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.